Cargando…
Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457441/ https://www.ncbi.nlm.nih.gov/pubmed/32865629 http://dx.doi.org/10.1007/s00415-020-10196-9 |
_version_ | 1783575994233257984 |
---|---|
author | Mantero, Vittorio Baroncini, Damiano Balgera, Roberto Guaschino, Clara Basilico, Paola Annovazzi, Pietro Zaffaroni, Mauro Salmaggi, Andrea Cordano, Christian |
author_facet | Mantero, Vittorio Baroncini, Damiano Balgera, Roberto Guaschino, Clara Basilico, Paola Annovazzi, Pietro Zaffaroni, Mauro Salmaggi, Andrea Cordano, Christian |
author_sort | Mantero, Vittorio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7457441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-74574412020-09-01 Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis Mantero, Vittorio Baroncini, Damiano Balgera, Roberto Guaschino, Clara Basilico, Paola Annovazzi, Pietro Zaffaroni, Mauro Salmaggi, Andrea Cordano, Christian J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-08-31 2021 /pmc/articles/PMC7457441/ /pubmed/32865629 http://dx.doi.org/10.1007/s00415-020-10196-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editors Mantero, Vittorio Baroncini, Damiano Balgera, Roberto Guaschino, Clara Basilico, Paola Annovazzi, Pietro Zaffaroni, Mauro Salmaggi, Andrea Cordano, Christian Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title | Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title_full | Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title_fullStr | Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title_full_unstemmed | Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title_short | Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
title_sort | mild covid‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457441/ https://www.ncbi.nlm.nih.gov/pubmed/32865629 http://dx.doi.org/10.1007/s00415-020-10196-9 |
work_keys_str_mv | AT manterovittorio mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT baroncinidamiano mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT balgeraroberto mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT guaschinoclara mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT basilicopaola mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT annovazzipietro mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT zaffaronimauro mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT salmaggiandrea mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis AT cordanochristian mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis |